Nykredit A S Makes New Investment in Ventas, Inc. $VTR

Key Points

• Nykredit A/S initiated a position in Ventas by purchasing 131,738 shares worth approximately $11.7 million during the second quarter. Institutional investors collectively own 94.18% of the healthcare REIT.
• Ventas exceeded quarterly expectations, reporting $0.97 in EPS versus the $0.96 consensus and $1.73 billion in revenue, up 21.7% year over year.
• The company declared a quarterly dividend of $0.52 per share, representing a $2.08 annualized payout and a 2.4% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $99.11.

Nykredit A S bought a new position in shares of Ventas, Inc. (NYSE:VTR - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 131,738 shares of the real estate investment trust's stock, valued at approximately $11,698,000.

Several other institutional investors have also modified their holdings of the business. Parkside Financial Bank & Trust raised its position in shares of Ventas by 23.7% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,981 shares of the real estate investment trust's stock valued at $176,000 after purchasing an additional 380 shares in the last quarter. Corient Private Wealth LP increased its stake in shares of Ventas by 114.8% in the second quarter. Corient Private Wealth LP now owns 170,259 shares of the real estate investment trust's stock worth $15,126,000 after buying an additional 91,003 shares during the last quarter. Amundi raised its holdings in Ventas by 7.3% in the second quarter. Amundi now owns 1,782,345 shares of the real estate investment trust's stock valued at $158,272,000 after acquiring an additional 121,816 shares in the last quarter. Advus Financial Partners LLC boosted its stake in Ventas by 17.2% during the 2nd quarter. Advus Financial Partners LLC now owns 4,932 shares of the real estate investment trust's stock valued at $438,000 after acquiring an additional 725 shares during the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Ventas during the 2nd quarter worth $17,244,000. Institutional investors and hedge funds own 94.18% of the company's stock.

Ventas Stock Performance

Shares of NYSE VTR opened at $86.70 on Monday. The stock has a fifty day moving average price of $92.47 and a two-hundred day moving average price of $88.03. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The firm has a market cap of $44.47 billion, a P/E ratio of 160.55, a PEG ratio of 3.38 and a beta of 0.70. Ventas, Inc. has a 1 year low of $66.54 and a 1 year high of $101.60.

Ventas (NYSE:VTR - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The company had revenue of $1.73 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the previous year, the business earned $0.87 EPS. The company's quarterly revenue was up 21.7% compared to the same quarter last year. Research analysts forecast that Ventas, Inc. will post 3.89 EPS for the current fiscal year.

Ventas Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.08 annualized dividend and a yield of 2.4%. Ventas's dividend payout ratio is currently 385.19%.

Wall Street Analyst Weigh In

VTR has been the topic of a number of recent analyst reports. BMO Capital Markets upped their target price on shares of Ventas from $105.00 to $107.00 and gave the company an "outperform" rating in a research note on Tuesday, August 11th. Weiss Ratings upgraded Ventas from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $100.00 price objective on shares of Ventas in a report on Tuesday, June 16th. Wells Fargo & Company upped their price objective on Ventas from $96.00 to $104.00 and gave the company an "overweight" rating in a research note on Tuesday, September 1st. Finally, Royal Bank Of Canada increased their target price on Ventas from $98.00 to $99.00 and gave the stock an "outperform" rating in a report on Friday, August 14th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $99.11.

About Ventas

Ventas, Inc is a real estate investment trust (REIT) that owns and manages a diversified portfolio of healthcare and senior living properties. Its real estate platform includes senior housing communities, medical office buildings, life science and innovation centers, and other healthcare-related facilities.

The company generally leases or operates its properties through relationships with healthcare providers, senior living operators, universities, and research institutions. Its properties support services such as independent and assisted living, skilled nursing, outpatient care, physician practices, medical research, and biotechnology development.

Ventas serves major healthcare and life science markets in the United States and Canada.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.